N. Mossaheb

I. Craig, A. Farmer, P. McGuffin, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial

I. Hickie, G. Cagney, S. Smesny, 2022, Brain, Behavior, and Immunity.

Neuropathological Variability within a Spectrum of NMDAR‐Encephalitis

G. Ricken, H. Lassmann, N. Mossaheb, 2021, Annals of neurology.

NEURAPRO: A Multi-Centre RCT of Omega-3 Polyunsaturated Fatty Acids versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders

I. Hickie, M. Nordentoft, A. Riecher-Rössler, 2017 .

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

I. Hickie, S. Smesny, M. Nordentoft, 2019, Schizophrenia Research.

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

I. Hickie, M. Nordentoft, A. Riecher-Rössler, 2020, Biological Psychiatry.

History of trauma and the association with baseline symptoms in an Ultra-High Risk for psychosis cohort

A. Yung, B. Nelson, L. Haan, 2013, Psychiatry Research.

Psychotic-Like Experiences: A Challenge in Definition and Assessment

N. Mossaheb, B. Hinterbuchinger, 2021, Frontiers in Psychiatry.

The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial

I. Hickie, S. Smesny, M. Nordentoft, 2021, Brain, Behavior, and Immunity.

Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes

I. Hickie, S. Smesny, M. Nordentoft, 2019, Schizophrenia Research.

The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo

I. Hickie, S. Smesny, M. Nordentoft, 2017, Schizophrenia Research.

Effect of &ohgr;-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial

I. Hickie, M. Nordentoft, A. Riecher-Rössler, 2017, JAMA psychiatry.

NEURAPRO‐E study protocol: a multicentre randomized controlled trial of omega‐3 fatty acids and cognitive‐behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders

I. Hickie, S. Smesny, M. Nordentoft, 2017, Early intervention in psychiatry.

Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians

F. Leisch, S. Kasper, K. Fuchs, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Emotion recognition in individuals at clinical high-risk for schizophrenia.

Barnaby Nelson, Patrick D McGorry, P. McGorry, 2012, Schizophrenia bulletin.

Role of aripiprazole in treatment-resistant schizophrenia

N. Mossaheb, R. Kaufmann, 2012, Neuropsychiatric disease and treatment.

[Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis].

N. Mossaheb, F. Friedrich, B. Hinterbuchinger, 2016, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study

Rupert Lanzenberger, Christoph Spindelegger, Siegfried Kasper, 2007, Psychopharmacology.

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram

R. Lanzenberger, J. Sacher, S. Kasper, 2006, Psychopharmacology.

Omega-3 Fatty Acid Supplementation in Adolescents with Borderline Personality Disorder and Ultra-High Risk Criteria for Psychosis: A Post Hoc Subgroup Analysis of a Double—Blind, Randomized Controlled Trial

S. Ohmann, A. Bechdolf, A. Yung, 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Effects of Olanzapine and Ziprasidone on Glucose Tolerance in Healthy Volunteers

J. Sacher, S. Kasper, N. Mossaheb, 2008, Neuropsychopharmacology.

Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis

I. Hickie, S. Smesny, R. Hester, 2020, Early intervention in psychiatry.

Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram

Rupert Lanzenberger, Christoph Spindelegger, Siegfried Kasper, 2009, International clinical psychopharmacology.

Long-Chain Omega-3 Fatty Acids and Psychotic Disorders

S. Smesny, P. Fusar-Poli, P. McGorry, 2013 .

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial.

I. Hickie, S. Smesny, M. Nordentoft, 2019, Behaviour research and therapy.

Predictors of longer-term outcome in the Vienna omega-3 high-risk study

S. Smesny, P. McGorry, N. Mossaheb, 2017, Schizophrenia Research.

On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study

G. Dorffner, L. Bartova, B. Meyer, 2020, Translational Psychiatry.

Do patients with different psychiatric disorders show altered social decision-making? A systematic review of ultimatum game experiments in clinical populations

N. Mossaheb, F. Friedrich, B. Hinterbuchinger, 2018, Cognitive neuropsychiatry.

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: When do they begin to be effective?

P. McGorry, N. Mossaheb, C. Klier, 2013, Schizophrenia Research.

Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processing

D. Van De Ville, C. Sandini, D. Zoller, 2020, medRxiv.

Late-onset depression in elderly subjects from the Vienna Transdanube Aging (VITA) study.

S. Zehetmayer, P. Fischer, N. Mossaheb, 2009, The Journal of clinical psychiatry.

Lithium in drinking water and suicide mortality

N. Praschak-Rieder, M. Willeit, N. Kapusta, 2011, British Journal of Psychiatry.

Aripiprazole-induced psychosis: a case report of reexposure by stepwise up-titration.

N. Kapusta, N. Mossaheb, P. Fischer, 2007, The Journal of clinical psychiatry.

Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.

G. Heinze, J. Sacher, S. Kasper, 2007, The international journal of neuropsychopharmacology.

P.3.c.037 Haloperidol in combination with clozapine in treatment-refractory patients with schizophrenia

J. Sacher, S. Kasper, N. Mossaheb, 2006, European Neuropsychopharmacology.

The Importance of Metacognitive Functioning in Individuals at Ultra-High Risk for Psychosis - A Systematic Review

N. Mossaheb, F. Friedrich, B. Hinterbuchinger, 2016 .

Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values

Peter B. Jones, N. Mossaheb, J. Stochl, 2017, Schizophrenia Research.

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION

I. Hickie, S. Smesny, M. Nordentoft, 2018, Schizophrenia Bulletin.

Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.

N. Mossaheb, C. Klier, A. Saria, 2007, Journal of clinical psychopharmacology.

Changes in triglyceride levels in ultra‐high risk for psychosis individuals treated with omega‐3 fatty acids

N. Mossaheb, K. Papageorgiou, G. Amminger, 2018, Early intervention in psychiatry.

Are specific symptoms of depression predictive of Alzheimer's dementia?

S. Zehetmayer, P. Fischer, N. Mossaheb, 2012, Journal of Clinical Psychiatry.

Psychotic-like experiences in non-clinical subgroups with and without specific beliefs

N. Mossaheb, E. Meyer, F. Friedrich, 2023, BMC Psychiatry.

Case report: Intestinal atonia as an unusual symptom of malignant catatonia responsive to electroconvulsive therapy

S. Kasper, R. Frey, N. Mossaheb, 2006, Schizophrenia Research.

The Impact of Sex Differences on Odor Identification and Facial Affect Recognition in Patients with Schizophrenia Spectrum Disorders

H. Traue, H. Hoffmann, S. Zehetmayer, 2018, Front. Psychiatry.

Affect recognition and functioning in putatively prodromal individuals

A. Bechdolf, B. Nelson, N. Mossaheb, 2013, Schizophrenia Research.

Facial and vocal affect perception in people at ultra‐high risk of psychosis, first‐episode schizophrenia and healthy controls

A. Bechdolf, P. McGorry, B. Nelson, 2012, Early intervention in psychiatry.

The role of estrogen and progesterone in depression after birth.

N. Mossaheb, C. Klier, B. Ulm, 2007, Journal of psychiatric research.

Psychotic-like experiences in non-clinical subgroups with and without specific beliefs

N. Mossaheb, E. Meyer, F. Friedrich, 2023, BMC Psychiatry.

Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine

N. Mossaheb, S. Asenbaum, P. Fischer, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

Sumudu R. Mallawaarachchi, I. Hickie, S. Smesny, 2020, Schizophrenia Research.

Duration of untreated psychosis in a high-income versus a low- and middle-income region

S. Zehetmayer, N. Mossaheb, C. Klier, 2013, The Australian and New Zealand journal of psychiatry.

Joint approximate point spectrum of elements of C-algebras

N. Mossaheb, 1979 .

Role of aripiprazole in treatment-resistant schizophrenia

N. Mossaheb, R. Kaufmann, 2012 .

Personality functioning and self-disorders in individuals at ultra-high risk for psychosis, with first-episode psychosis and with borderline personality disorder

S. Doering, N. Mossaheb, V. Blüml, 2023, BJPsych Open.

Emotion recognition in individuals at clinical high-risk for schizophrenia.

P. McGorry, B. Nelson, N. Mossaheb, 2012, Schizophrenia bulletin.